In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d.

Authors :: Granwehr B
Source :: Annals of internal medicine [Ann Intern Med] 2024 Jun; Vol. 177 (6), pp. JC67. Date of Electronic Publication: 2024 Jun 04.
Publication Year :: 2024
Abstract: Source Citation: Wagenlehner FM, Gasink LB, McGovern PC, et al; CERTAIN-1 Study Team. Cefepime-taniborbactam in complicated urinary tract infection. N Engl J Med. 2024;390:611-622. 38354140.<br />Competing Interests: Disclosures: Disclosure forms are available with the article online.

Subjects :: Female
Humans
Male
Middle Aged
Drug Combinations
Treatment Outcome
Randomized Controlled Trials as Topic
Anti-Bacterial Agents therapeutic use
Anti-Bacterial Agents adverse effects
Cefepime therapeutic use
Meropenem therapeutic use
Urinary Tract Infections drug therapy

Full Text Access

Tools